Physicians Interactive acquires online sampling provider

Share this article:
Physicians Interactive (PI) acquired MedManage Systems Inc., a provider of online, on-demand prescription drug sampling. 

Under the terms of the agreement, MedManage is now a wholly owned subsidiary of PI. The acquisition of MedManage, is part of PI's strategy to support the expanding digital sales and marketing information needs of life science companies and their healthcare professional customers.

Donato Tramuto, CEO and vice chairman of PI, said that MedManage is a valuable addition to the PI family. He noted that MedManage provides more direct-to-practitioner eSampling solutions to more major pharma companies and its brands than anyone else in the industry. Tramuto added the acquisition aligns nicely with PI's digital strategy and allows the company to expand its value proposition to its customers in the life sciences industry.

MedManage's eSampling solutions allow life sciences companies to reach more healthcare providers via its web-based Samples On Demand service, powered by the company's regulatory compliant e-drug sampling platform. With Samples On Demand, healthcare providers can obtain consistent supplies of samples to meet the needs of their patients by accessing the Sample Service via PI and other web-based portals operated by independent providers of medically relevant information and services, pharma companies and healthcare organizations.  
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.